Scientists move to commercialize new isotope production method

02/22/2012 | Reuters

Researchers at the TRIUMF laboratory in Vancouver, British Columbia, are in talks with several companies, including Cardinal Health, Covidien, GE Healthcare, Lantheus Medical Imaging and Nordion, over the business potential of producing the technetium-99m medical isotope using a cyclotron. The process utilizes molybdenum-100 and eliminates the need for a nuclear reactor.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ